Arab World vs United Kingdom of Great Britain and Northern Ireland: Access to anti-retroviral drugs, female

Arab World
48.4%
in 2024
United Kingdom of Great Britain and Northern Ireland
96.0%
in 2023
Arab World rank
16th
United Kingdom of Great Britain and Northern Ireland rank
14th

Access to anti-retroviral drugs, female over time

  • Arab World
  • United Kingdom of Great Britain and Northern Ireland
020406080100200020122024

How they compare

United Kingdom of Great Britain and Northern Ireland currently reports 96.0% against 48.4% in Arab World, a difference of 47.6%.

That makes United Kingdom of Great Britain and Northern Ireland's figure about 2.0 times Arab World's.

Across all 8 years both countries report, United Kingdom of Great Britain and Northern Ireland has been ahead every year.

Arab World ranks 16th and United Kingdom of Great Britain and Northern Ireland ranks 14th of 19 groups.

United Kingdom of Great Britain and Northern Ireland has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Arab World United Kingdom of Great Britain and Northern Ireland Difference Ahead
2010s 38.8% 88.0% 49.2% United Kingdom of Great Britain and Northern Ireland
2020s 46.5% 90.8% 44.2% United Kingdom of Great Britain and Northern Ireland

Averages of every year both report within each decade.

Frequently asked questions

Which has higher access to anti-retroviral drugs, female, Arab World or United Kingdom of Great Britain and Northern Ireland?
United Kingdom of Great Britain and Northern Ireland, at 96.0% against 48.4% in Arab World as of 2023.
What is the difference in access to anti-retroviral drugs, female between Arab World and United Kingdom of Great Britain and Northern Ireland?
47.6%, with United Kingdom of Great Britain and Northern Ireland ahead.
How many years of comparable data are there for Arab World and United Kingdom of Great Britain and Northern Ireland?
8 years are reported by both, from 2016 to 2023.
How do Arab World and United Kingdom of Great Britain and Northern Ireland rank globally for access to anti-retroviral drugs, female?
Arab World ranks 16th and United Kingdom of Great Britain and Northern Ireland ranks 14th of 19 groups.
Where does this data come from?
UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Arab World vs United Kingdom of Great Britain and Northern Ireland: Access to anti-retroviral drugs, female. Statizoid, drawing on UNAIDS estimates. Retrieved 17 September 2026, from https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-female-percent/arab-world/united-kingdom/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/compare/access-to-anti-retroviral-drugs-female-percent/arab-world/united-kingdom/">Arab World vs United Kingdom of Great Britain and Northern Ireland: Access to anti-retroviral drugs, female</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.